Healthcare Business and Asset Valuation Frequently Asked Questions
When is a healthcare business or asset valuation typically needed?
A valuation may be needed for a sale, acquisition, physician buy-in or buy-out, joint venture, divestiture, restructuring, financial reporting, tax planning, regulatory review, or dispute. The intended use should be established at the beginning because it determines what must be valued and how the analysis should be documented.
What is the difference between valuing a healthcare entity and valuing its individual assets?
An entity valuation analyzes the healthcare business as an operating whole. An asset valuation isolates specific tangible or intangible assets, such as fixed assets, real estate, technology, intellectual property, brand, non-compete agreements, or personal goodwill. A transaction or reporting requirement may call for one or both types of analysis.
Which intangible assets can matter in a healthcare transaction?
Depending on the facts, relevant intangible assets may include brand, healthcare technology and data, intellectual property, non-compete agreements, and personal goodwill. Each asset should be evaluated separately rather than assumed to have value because its contribution depends on the rights transferred, its expected use, and the circumstances of the transaction.
How can healthcare-specific operating issues affect a valuation?
Reimbursement, revenue cycle performance, compliance considerations, strategy, tax, and financial reporting requirements can affect the assumptions and documentation used in a healthcare valuation. These issues should be considered in the context of the specific entity, asset, and transaction rather than evaluated in isolation.
What should an organization define before a healthcare valuation begins?
The organization should clarify the purpose of the valuation, the entity or assets being valued, the relevant ownership interest, the proposed transaction structure, applicable reporting or regulatory requirements, available financial and operating information, and the decision timeline. This helps prevent a valuation prepared for one purpose from being used inappropriately for another.
